As part of Thermo Fisher Scientific, we offer products and services to advance the science of transplant diagnostics. Our solutions help transplant labs and clinical teams provide personalized care across the patient experience.
Dr. Paul Terasaki founded One Lambda™ in 1984 with the goal of developing tests to improve how laboratories match and monitor transplant recipients and donors. Since then, our HLA typing and antibody detection assays have been trusted by transplant laboratories worldwide. Clinicians also rely on data from our patient monitoring tests to make important decisions about post-transplant therapies.
Transplantation is life-changing for recipients, and clinical diagnostics play a vital role in supporting all phases of treatment. Through our commitment to scientific innovation, product quality, patient advocacy, and excellent customer service, we are helping the transplant community raise the standard of care and improve outcomes for patients and their families.